Dark-adapted red flash ERGs in healthy adults by Hamilton, R. & Graham, K.
ORIGINAL RESEARCH ARTICLE
Dark-adapted red flash ERGs in healthy adults
R. Hamilton . K. Graham
Received: 22 February 2018 / Accepted: 22 May 2018
 The Author(s) 2018
Abstract
Purpose The x-wave of the dark-adapted (DA) ERG
to a red flash reflects DA cone function. This
exploratory study of healthy adults aimed to investi-
gate changes in the DA red ERG with flash strength
and during dark adaptation to optimise visualisation
and therefore quantification of the x-wave.
Methods The effect of altering red flash strength was
investigated in four subjects by recording ERGs after
20 min dark adaptation to red flashes
(0.2–2.0 cd s m-2) using skin electrodes and natural
pupils. The effect of dark adaptation duration was
investigated in 16 subjects during 20 min in the dark,
by recording DA 1.5 red ERGs at 1, 2, 3, 4, 5, 10, 15
and 20 min.
Results For a dark adaption period of 20 min, the
x-wave was more clearly visualised to weaker
(\ 0.6 cd s m-2) red flash strengths: to stronger
flashes it became obscured by the b-wave. For red
flashes of 1.5 cd s m-2, the x-wave was most promi-
nent in ERGs recorded after 1–5 min of dark adapta-
tion: with longer dark adaptation, it was subsumed into
the b-wave’s rising edge.
Conclusions This small study suggests that x-wave
visibility in healthy subjects after 20 min dark adap-
tation is improved by using flashes weaker than around
0.6 cd s m-2; for flash strengths of 1.5 cd s m-2,
x-wave visibility is enhanced by recording after only
around 5 min of dark adaptation. No evidence was
found that interim red flash ERGs affect the dark-
adapted state of the normal retina.
Keywords ISCEV standard  Dark-adapted red flash
ERG  x-wave  Dark-adapted
Introduction
The dark-adapted (DA) ERG to a red flash has an
initial positive peak called the x-wave [1, 2] which is
seen only in species with cone-rich retinae [3]. X-wave
amplitude is largest to wavelengths around 630 nm
[2–4], and increases during dark adaptation, peaking
within a few minutes [4–6]. Its peak time, unlike the
b-wave, changes little with wavelength [7]. Visibility
of the x-wave can be enhanced by using a dim
background to suppress rods [4, 8].
No x-wave is evident in protanomalous subjects
[4, 7, 9] nor in subjects with achromatopsia [7, 9].
Conversely, the x-wave is preserved but the b-wave is
attenuated or absent in RDH5 retinopathy (fundus
albipunctatus) [10, 11] and in vitamin A deficiency
R. Hamilton (&)  K. Graham
Department of Clinical Physics and Bio-Engineering,
NHS Greater Glasgow and Clyde, Glasgow, UK
e-mail: ruth.hamilton@glasgow.ac.uk
R. Hamilton  K. Graham
College of Medical, Veterinary and Life Sciences,




[12]. The DA ERG to a red flash is present—albeit
with impaired kinetics [13]—in bradyopsia (RGS9/
R9AP mutation), indicating preserved cone function,
whereas the light-adapted white flash ERG is absent, a
combination reported to be pathognomonic for the
condition [14]. The x-wave is, therefore, interpreted as
a measure of dark-adapted cone function. Although a
DA red ERG is not part of the ISCEV ERG standard
[15], it is used ‘sometimes’ or ‘often’ in around half of
visual electrophysiology clinics [16]. Red flash
strengths of 0.05–2.5 cd s m-2 [8, 10, 17–21] have
been used, but some studies report clinical use of the
red flash ERG without giving flash strength or spectral
characteristics, instead describing flash strength ‘‘such
that in a normal subject the amplitude of the rod
component to the red flash is equivalent to that of the
rod-specific response to a dim white flash (dark-
adapted 0.01 cd s m-2)’’ [11, 12, 14, 22].
The x-wave can be swamped by the later, larger rod
b-wave, appearing as only a shoulder which hampers
quantification [20, 21]. Clearer visualisation and
hence quantification of the x-wave might be achieved
by a suitable combination of red flash strength and
dark adaptation duration. This exploratory study
aimed to investigate changes in the DA red ERG with
flash strength and during dark adaptation.
Methods
The study was approved by the Ethics Committee of
the College of Medical, Veterinary and Life Sciences,
University of Glasgow. Subjects gave informed,
written consent.
Subjects
Sixteen adult subjects (20–58 years old) without self-
reported neurological or ocular conditions were
recruited without incentive. Inclusion criteria were
refractive errors of\ 3 dioptres, and a normal Ishihara
colour test result. The sample size was selected to
power a concomitant study of shorter dark adaptation
for ISCEV standard DA ERGs [23].
Study design
Subjects were restricted to interior lighting for at least
1 h prior to any recordings. The test room was
artificially lit. The first investigation explored the
effect of altering red flash strength on four subjects (all
female, aged 22–53). After 20 min dark adaptation,
ERGs were recorded as described below from one
random eye to red flashes of 0.2 or 0.3–2.0 phot
cd s m-2 in 0.1 steps. A white 0.01 phot cd s m-2
ERG (DA 0.01 ERG) was also recorded at each step
for comparison and to check for any evidence, e.g.
reducing amplitude, that the retina was becoming light
adapted.
The second investigation explored the effect of
altering duration of dark adaptation on the red flash
ERGs, and was conducted as part of the concomitant
study [23]. In the baseline phase of the experiment
(Fig. 1), subjects were dark adapted for 20 min, at the
end of which a DA 1.5 cd s m-2 red flash ERG
(followed by ISCEV standard DA 0.01 and DA 3.0
ERGs) was recorded. Subjects were then light adapted
to the artificial room lighting for 10 min before
beginning the experimental phase of the protocol. In
the experimental phase, dark adaptation was recom-
menced and interim DA 1.5 red ERGs were recorded
during this second 20-min dark adaptation period at 1,
2, 3, 4, 5, 10, 15 and 20 min. The baseline phase was
included in order to compare ERGs recorded after
20 min uninterrupted dark adaptation with those
recorded after 20 min dark adaptation punctuated
with multiple, interim ERGs, in order to test whether
the experimental design itself affected the ERGs.
ERGs
ERGs were recorded from both eyes using adhesive,
disposable skin electrodes placed on the lower lid,
referenced to skin electrodes at the ipsilateral temporal
orbital rim. A ground electrode was placed on a
mastoid. Skin was prepared to ensure low (\ 5 kX)
and matched impedances; amplifier bandpass was
0.3–300 Hz (IIR digital, 2 pole Bessel emulations),
with a sampling frequency of 1000 Hz. In the interests
of investigating protocols with greater patient test
acceptability, no dilating drops were used, contrary to
the stipulation of the ISCEV standard [15]. Pupil sizes
were measured towards the end of the baseline period
of dark adaptation using a half-moon rule with 0.5 mm
precision and an infrared camera. Diameters ranged
from 7 to 10 mm (median 8.5 mm), very similar to
those from an earlier study on similar subjects
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(7–9 mm) with mydriasis [24]. A dim red fixation
mark aided eye stability during recordings.
Stimulation and acquisition were driven by a visual
electrophysiology system (Espion, Diagnosys LLC,
Lowell, MA, USA). Ten ERGs were averaged with an
inter-stimulus interval of 1 s to ensure adequately high
SNR since skin electrodes were used. Flashes were
generated by LEDs within a ganzfeld (ColorDome,
Diagnosys LLC, Lowell, MA, USA) with stated peak
wavelength k = 635 nm and CIE coordinates
x = 0.702, y = 0.298. Annual manufacturer’s calibra-
tion before and after the investigation showed no
changes; values were confirmed for white flashes
using a photometer (ILT1700, International Light
Technologies, MA, USA) in integrating mode. Values
given here are manufacturer’s nominal values. For the
second investigation, a red flash strength of 1.5
(photopic) cd s m-2 was chosen somewhat arbitrarily,
as it fell within the range of flash strengths described
elsewhere for use with a preceding 20 min period of
dark adaptation (0.05–2.5 cd s m-2 [8, 10, 17–21]);
additionally, it generated a b-wave of a similar
amplitude to that produced by the DA 0.01 ERG
white flashes (Fig. 2).
Amplitudes of a-waves were measured from base-
line, and x- and b-waves were measured from a-wave
troughs. No systematic inter-ocular ERG differences
existed, so parameters from eyes of each subject were
averaged [25]. Data were treated nonparametrically
because of the small sample size and some skew.
Results
ERG changes with red flash strength
The red flash ERG grew in amplitude as flash strength
increased for all four subjects tested (Fig. 2). The
a-wave was present, typically at around 17–20 ms.
Two further troughs were evident, typically shallower,
at around 25–28 ms and at around 30–37 ms, depend-
ing on flash strength. The x-wave was also present,
typically at around 45–50 ms, and was more clearly
seen at lower than at higher flash strengths: as flash
strength increased, it became larger, but was increas-
ingly obscured by the b-wave, appearing as a shoulder
on the b-wave rising edge. At lower flash strengths, the
b-wave was also clearly visualised at around 100 ms,
with a similar form to the b-wave of the dim white
flash ERG. As red flash strength increased, the b-wave
shortened and merged with the x-wave peak.
The white flash DA 0.01 ERGs recorded at each
step showed no evidence of reducing in amplitude
over the 10 ERGs used for the average in each step, nor
over the whole investigation for any subject, despite a
1-s inter-stimulus interval, rather than the 2 s stipu-
lated in the ERG standard [15]. Similarly, the red flash
ERGs showed no evidence of reducing in amplitude
over the 10 ERGs used for the average in each step,
suggesting that, even for relatively strong red flashes, a
1-s inter-stimulus interval was adequate to maintain
the dark-adapted state of the retina.
Fig. 1 Timeline illustration of recording protocol. Black and white bands indicate dark and light adaptation, respectively. Boxes below
the timeline indicate ERG recordings, labelled by duration of dark adaptation after which they were made
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Fig. 2 Illustrative red flash ERGs (red traces) and ISCEV
standard DA 0.01 ERGs (grey traces) from subject #16, recorded
after 20 min dark adaptation (a). The numbers to the right of
each pair of traces indicate the strength of the red flash in
photopic cd s m-2. Right panels show effect of red flash
strength on subject #16’s peak times (b); x and b-wave
amplitudes (c) and a-wave amplitudes (d). Circles: a-waves,
diamonds: x-waves, squares: b-waves. Open symbols close to




ERG changes with duration of dark adaptation
Comparing ERGs recorded at the end of the baseline
phase with those recorded at the end of the experi-
mental phase revealed no statistically significant
differences in ERG parameters (Mann–Whitney
U tests, p values all C 0.50), establishing that interim
ERGs recorded during the experimental phase did not
affect the measured parameters of ERGs recorded at
the end of the dark adaptation period (Fig. 3). This
also implies that delivering red flashes with 1-s inter-
stimulus intervals does not affect the adaptation state
of the retina, notwithstanding the additional white
flashes delivered during the experimental phase [23].
The morphology of the DA 1.5 red ERG changes
during dark adaptation (Fig. 4). A series of oscillations
at the a-wave and rising edge of the b-wave are
evident, with the largest positive peak—the x-wave—
being most prominent at around 40 ms in ERGs
recorded after 1–5 min of dark adaptation. As the
presumably rod-driven, later b-wave gains amplitude
during dark adaptation, this 40-ms x-wave peak
becomes subsumed into the b-wave’s rising edge,
often being no longer apparent, or present as only a
shoulder with no following trough. A later oscillation,
usually[ 50 ms, is more clearly visualised as the
x-wave than the 40-ms peak in ERGs recorded after
10–20 min of dark adaptation.
The development of the DA red 1.5 ERG during
dark adaptation was quantified by normalising indi-
vidual subject’s ERG parameters to those of their
Fig. 3 Upper panels: scatterplots of ERG parameters recorded
at the end of baseline phase versus end of experimental phase for
all 16 subjects. Grey diagonal lines indicate equality. Lower
panels: corresponding difference plots. Grey horizontal lines
indicate the median difference between experimental and
baseline recordings, and grey dashed lines indicate the 5th and
95th percentiles of the difference
Fig. 4 Illustrative DA 1.5 red ERGs from a typical subject (#8).
The numbers to the right of each trace indicate the duration of
dark adaptation (minutes) before each ERG. Vertical grey lines
mark the two positive peaks which exchange dominance (largest
amplitude) as dark adaptation proceeds. The largest peak is
measured as the x-wave (continuous line). Note the triple trough




20 min DA ERG (Fig. 5). The red a-wave amplitude
reduced a little over the first 3 min of dark adaptation,
while peak times did not change at all over the whole
20 min. The x-wave amplitude increased, and peak
time lengthened between five and 10 min of dark
adaptation, primarily due to the later peak at * 50 ms
becoming dominant as the growing b-wave obscured
the earlier x-wave peak at * 40 ms. The b-wave
amplitude increased, and peak time shortened with
lengthening dark adaptation as might be expected for a
rod system b-wave.
Summarised reference data are presented in
Table 1 for the DA 1.5 red flash ERG after 5, 10 and
20 min of dark adaptation: data are presented as
ranges as the sample size is inadequate for percentiles
with confidence intervals [26]. These data do not
change substantially with duration of dark adaptation,
except for the x-wave peak time which more tightly







values; dashed lines: 95%
prediction intervals of
growth curves fitted to
median data; solid
horizontal line highlights the
100% level. Data are
normalised relative to values
after 20 min dark
adaptation, hence the lack of
variability at 20 min. Note




defined after 5 min in the dark than after longer dark
adaptation.
Discussion
In this small, exploratory study of healthy adult
subjects, we found that after 20 min of dark adapta-
tion, the x-wave was more clearly visualised with
weaker (about 0.6 cd s m-2 or less) than with stronger
flashes, as described elsewhere [18]. We also found
that that with a relatively strong 1.5 cd s m-2 red
flash, the x-wave was more clearly visualised after
shorter (about 5 min or less) than longer dark adap-
tation, also confirming findings elsewhere [6].
The subjects in this study were mostly in their
second or third decades, so findings cannot be
generalised to all age groups. As an exploratory study,
we chose a minimally invasive protocol with non-
corneal electrodes and no mydriasis: this will have
resulted in higher signal-to-noise ratios than usually
found with corneal electrodes. This is unlikely to
affect conclusions since mostly relative outcome
measures were used, but signal noise increases uncer-
tainty of peak labelling in some instances.
The DA red flash ERG is quite widely used, and the
International Society for Clinical Electrophysiology
of Vision has recently prepared a new Extended
Protocol to inform current and potential users. Its
utility lies in an extant x-wave revealing the presence
of functioning, dark-adapted cones. Thus, the visibil-
ity of the x-wave is of primary importance for the
optimisation of protocols. The current findings suggest
that x-wave visibility in normal subjects is impaired by
flashes stronger than around 0.6 cd s m-2 (for 20 min
dark adaptation), or by dark adaptation longer than
around 5 min (for flash strengths of 1.5 cd s m-2).
Other combinations remain uninvestigated. It seems
feasible that the ISCEV standard dark-adapted ERG
protocol could incorporate a dim red flash ERG
delivered at some point during the currently stipulated
20 min of dark adaptation, adding no further burden of
time to the patient or tester. These data also suggest
that additional flashes, even delivered once per
second, are unlikely to affect the dark-adapted state
of the normal retina, although this may not be the case
for patients with retinal dysfunction.
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Table 1 Summarised reference data (ranges) for DA 1.5 red flash ERGs, skin electrodes, undilated pupils, N = 16 subjects
Duration of dark adaptation (min) a-wave x-wave b-wave
Amplitude (lV) PT (ms) Amplitude (lV) PT (ms) Amplitude (lV) PT (ms)
5 5.2–24 15–20 31–100 41–50 21–97 62–89
10 6.3–25 15–19 38–110 41–58 40–128 66–92
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